Beacon Pointe Advisors »

Lyra Therapeutics shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $20k 77k 0.26

More positions owned by Beacon Pointe Advisors

Apple Call Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Beacon Pointe Advisors

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
BlackRock
BlackRock
Samsara BioCapital
Vanguard Group
Ikarian Capital
Sei Investments
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Everhart Financial Group
Northern Trust

View all funds holding Lyra Therapeutics